Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    P1.03 - Chemotherapy/Targeted Therapy

    • 09:30 - 16:00
    • 10/16/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
  • +

    P1.15 - SCLC/Neuroendocrine Tumors

    • 09:30 - 16:00
    • 10/16/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: SCLC/Neuroendocrine Tumors
  • +

    P2.02 - Biology/Pathology

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Biology/Pathology
  • +

    P2.03 - Chemotherapy/Targeted Therapy

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • +

      P2.03-028 - Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial

      09:30 - 09:30  |  Presenter: Yuankai Shi  |  Author(s): X. Hu, S. Zhang, N. Yang, Y. Zhang, W. Li, X. Han, H. Mo, Y. Sun

      • Abstract

      Loading...

    • +

      P2.03-040 - EGFR T790M Mutation Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Advanced NSCLC Patients

      09:30 - 09:30  |  Presenter: Chenguang Li  |  Author(s): H. Liu, Bin Zhang, Z. Zhang, Y. Su, C. Wang

      • Abstract

      Loading...

  • +

    P2.14 - Radiotherapy

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Radiotherapy
  • +

    P2.15 - SCLC/Neuroendocrine Tumors

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: SCLC/Neuroendocrine Tumors
    • +

      P2.15-003 - A Long Non-Coding RNA HOTTIP Expression Is Associated with Disease Progression and Predicts Outcome in Small Cell Lung Cancer Patients

      09:30 - 09:30  |  Presenter: Linlang Guo  |  Author(s): Y. Sun, Qiongyao Wang, J. Bao, Fanrui Zeng

      • Abstract

      Loading...

    • +

      P2.15-010 - Etk Interacting with PFKFB4 Modulates Chemoresistance of Small Cell Lung Cancer by Regulating Autophagy

      09:30 - 09:30  |  Presenter: Qiongyao Wang  |  Author(s): Fanrui Zeng, Y. Sun, Q. Qiu, J. Zhang, L. Guo

      • Abstract

      Loading...

  • +

    MA 10 - Immunotherapy I

    • 11:00 - 12:30
    • 10/17/2017
    • Location: Room 303 + 304
    • Type: Mini Oral
    • Track: Immunology and Immunotherapy
  • +

    MA 11 - Emerging Diagnostic/Biomarkers in NSCLC

    • 11:00 - 12:30
    • 10/17/2017
    • Location: Room 313 + 314
    • Type: Mini Oral
    • Track: Advanced NSCLC
  • +

    P3.07 - Immunology and Immunotherapy

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy